局限性前列腺癌患者合并症与治疗后悔的关联:基于人群队列结果
该前瞻性人群队列纳入981例局限性前列腺癌患者,采用经验证的后悔量表在治疗后12个月评估决策后悔。多因素分析显示合并症评分越高、未结婚、肠道症状加重及泌尿梗阻/刺激症状加重与后悔增加相关,而放疗相比根治性前列腺切除术后悔更少。
要点
- 基线合并症负担越重,治疗后12个月决策后悔风险越高(OR 1.58)。
- 放疗相比根治性前列腺切除术与更少的决策后悔相关(OR 0.48)。
- 肠道症状加重(OR 2.12)和泌尿梗阻/刺激症状加重(OR 1.60)与后悔增加相关。
核心结论
- 在局限性前列腺癌男性中,基线合并症负担与增加的决策后悔相关,应将基线合并症评估纳入治疗决策过程以确保患者有现实预期并做出知情决策。
研究设计与样本
- 前瞻性、基于人群的局限性前列腺癌患者队列,共981例,采用经验证量表在治疗后12个月评估患者报告的决策后悔。
- 合并症通过病历摘录评估并使用经验证的国家癌症研究所合并症指数评分。
- 采用多因素logistic回归评估合并症评分与后悔的关联,并校正治疗相关症状、接受的治疗及社会人口学指标。
主要发现
- 队列具有多样性,黑人患者占25.3%,农村地区居民占24.2%。
- 981例患者中108例(11%)报告后悔。
- 多因素分析中,合并症评分(OR 1.58;p < .05)、未结婚(OR 1.72;p = .04)、肠道症状加重(OR 2.12;p < .01)及泌尿梗阻/刺激症状加重(OR 1.60;p = .05)与决策后悔相关。
- 放疗相比根治性前列腺切除术与更少的后悔相关(OR 0.48;p = .015)。
临床怎么用
- 在局限性前列腺癌治疗决策前应系统评估基线合并症,并将其纳入共同决策以设定现实预期。
- 对合并症负担重、未结婚或治疗后肠道/泌尿症状加重的患者,应加强预期管理和症状支持。
- 与根治性前列腺切除术相比,放疗可能与更低的决策后悔相关,可作为医患沟通的参考信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Decision regret is a well-established negative outcome in prostate cancer. We hypothesized that baseline comorbidities, which impact treatment tolerability, are associated with regret. METHODS AND MATERIALS: In a prospective, population-based cohort of patients with prostate cancer, patient-reported regret was assessed at 12 months after treatment using a validated measure. Comorbidities were assessed using medical record abstraction and scored using the validated National Cancer Institute Comorbidity Index. Multivariable logistic regression was used to assess the association between the comorbidity score and regret, accounting for treatment-related symptoms, treatment received, and sociodemographic measures. RESULTS: This was a diverse cohort, comprising 25.3% Black patients and 24.2% living in rural areas. A total of 108 out of 981 patients (11%) reported regret. In multivariable analysis, comorbidity score (odds ratio [OR], 1.58; p < .05), not being married (OR, 1.72; p = .04), worsening of bowel symptoms (OR, 2.12; p < .01), and worsening of urinary obstruction/irritation (OR, 1.60; p = .05) were associated with decision regret. In addition, radiation therapy was associated with less regret compared with radical prostatectomy (OR, 0.48; p = .015). CONCLUSIONS: Among men with localized prostate cancer, baseline comorbidity burden was associated with increased decision regret. These results illustrate the importance of assessing baseline comorbidities and incorporating their consideration into the treatment decision-making process, ensuring that patients have realistic expectations and make informed decisions.
引用
- Mali RD, Cao Y, Katz AJ, et al. Association of Patient Comorbidities With Treatment Regret Among Patients With Localized Prostate Cancer - Results From a Population-Based Cohort. Pract Radiat Oncol. 2025. PMID: 40889640. doi:10.1016/j.prro.2025.07.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。